Cited by 4Oral microbiology and periodontitis researchDental Health and Care UtilizationOral Health Pathology and Treatment

Oral carriage of cariogenic bacteria and Candida albicans in asthmatic adults before and after anti-asthma medication: A longitudinal study

Open access
Nandini, DB, Ashuja, RB, Vidyasagar, B, Ashwini, R, Donoghue, Mandana, Madhushankari, GS·2018·Journal of Oral and Maxillofacial Pathology

Abstract

Background: Antiasthmatic medications such as β2 agonists and corticosteroids have shown potential side effects such as increased caries risk and oral candidiasis. Studies evaluating microbial changes in adult asthmatics are very scanty in the literature. The present study aimed to evaluate the effects of asthma and its medication on cariogenic bacteria and Candida albicans in adult asthmatics. Aim and Objectives: Our aim was to evaluate and compare counts of Streptococcus mutans (SM) and lactobacilli in plaque and C. albicans in saliva samples of adult asthmatics with controls and during the course of medication longitudinally. Methodology: Samples were collected from twenty recently diagnosed asthmatic adults and twenty controls for estimation of microbial counts at baseline and at 3rd and 6th month after initiation of medication among cases. Results: Asthmatics at baseline had higher microbial counts than controls, but the difference was not statistically significant. Comparison between asthmatics at baseline and 3rd month after initiation of medication showed an increase in counts of SM, lactobacilli and decreased C. albicans counts though the difference was not significant. Comparison between asthmatics at baseline and 6th month and also between 3rd and 6th month showed significantly increased counts of SM. Although there was an increase in counts of lactobacilli and decreased C. albicans counts, significant results were not noted. Asthmatics showed increased microbial counts than controls overall. Conclusion: Asthmatics were found to have higher microbial counts than controls at baseline. Increase in SM and lactobacilli counts in asthmatics after medication emphasizes the need to monitor these patients regularly.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/jomfp.jomfp_235_15

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The relationship between inhaled corticosteroids and oral candidiasis is mainly due to decreases in salivary IgA and histamine from immunosuppressant actions, and to suppression of cellular immunity and phagocytosis.

    “in addition to suppressing cellular immunity and phagocytosis.”

    From Drugs Prescribed for Asthma and Their Adverse Effects on Dental Health (2023) · cites this paper as [50]

    The Introduction says corticosteroid use increases the risk of oral candidiasis, and the Discussion identifies cell-mediated immunity and macrophages as host factors in candidal pathogenicity. Neither section says inhaled corticosteroids suppress cellular immunity or phagocytosis, or that reduced salivary IgA and histamine explain the relationship. The Discussion also reports no significant change in candidal counts in this study. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Only 20% of the inhaled corticosteroid dose actually reaches the lungs; most remains in the oral cavity and oropharynx.

    “considering that only 20% of the inhaled dose actually reaches the lungs, so most of the inhaled drug remains in the oral cavity and oropharynx”

    From Drugs Prescribed for Asthma and Their Adverse Effects on Dental Health (2023) · cites this paper as [50]

    The Introduction discusses oral side effects of corticosteroids, and the Methodology records inhaler use, but neither gives the proportion of an inhaled dose reaching the lungs or remaining in the mouth and oropharynx. Searches for the 20% figure and for lung and oropharyngeal deposition found no supporting passage in our copy. (LLM, conf=0.72)

    Experimental — accuracy not yet measured
  • Oral mucosal immunity normalizes upon discontinuation of corticosteroids.

    “However, it has been reported that oral mucosal immunity normalizes upon discontinuation of corticosteroids [50,59,89,90,91,92].”

    From Drugs Prescribed for Asthma and Their Adverse Effects on Dental Health (2023) · cites this paper as [50]

    The Introduction (page unavailable) says corticosteroid use increases the risk of oral candidiasis, and the Results (page unavailable) compare asthmatic adults before and after starting medication. Neither passage addresses whether oral mucosal immunity normalizes after corticosteroids are discontinued. Searches for discontinuation, withdrawal, and immune recovery found no such finding in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 24

  1. [1]Stensson M Wendt LK Koch G Oldaeus G Ramberg P Birkhed D Oral health in young adults with long-term, controlled asthma Acta Odontol Scand 2011 69 158 64 21231815
  2. [2]Ryberg M Möller C Ericson T Saliva composition and caries development in asthmatic patients treated with beta 2-adrenoceptor agonists: A 4-year follow-up study Scand J Dent Res 1991 99 212 8 1871531
  3. [3]Ellepola AN Samaranayake LP Inhalational and topical steroids, and oral candidosis: A mini review Oral Dis 2001 7 211 6 11575870
  4. [4]Ryberg M Möller C Ericson T Effect of beta 2-adrenoceptor agonists on saliva proteins and dental caries in asthmatic children J Dent Res 1987 66 1404 6 2887602
  5. [5]Godara N Godara R Khullar M Impact of inhalation therapy on oral health Lung India 2011 28 272 5 22084541 PMC3213714
  6. [6]Hugoson A Koch G Slotte C Bergendal T Thorstensson B Thorstensson H Caries prevalence and distribution in 20-80-year-olds in Jönköping, Sweden, in 1973, 1983, and 1993 Community Dent Oral Epidemiol 2000 28 90 6 10730716
  7. [7]Hirasawa M Takada K A new selective medium for Streptococcus mutans and the distribution of S. mutans and S. sobrinus and their serotypes in dental plaque Caries Res 2003 37 212 7 12740546
  8. [8]Wu H Fan M Zhou X Mo A Bian Z Zhang Q Detection of Streptococcus mutans and Streptococcus sobrinus on the permanent first molars of the mosque people in China Caries Res 2003 37 374 80 12925830
  9. [9]Sigurjóns H Magnúsdóttir MO Holbrook WP Cariogenic bacteria in a longitudinal study of approximal caries Caries Res 1995 29 42 5 7867049
  10. [11]Dubus JC Marguet C Deschildre A Mely L Le Roux P Brouard J Local side-effects of inhaled corticosteroids in asthmatic children: Influence of drug, dose, age, and device Allergy 2001 56 944 8 11576072
  11. [12]Bjerkeborn K Dahllöf G Hedlin G Lindell M Modéer T Effect of disease severity and pharmacotherapy of asthma on oral health in asthmatic children Scand J Dent Res 1987 95 159 64 3470909
  12. [13]Arnrup K Lundin SA Dahllöf G Analysis of paediatric dental services provided at a regional hospital in Sweden. Dental treatment need in medically compromised children referred for dental consultation Swed Dent J 1993 17 255 9 8134895
  13. [14]Mazzoleni S Stellini E Cavaleri E Angelova Volponi A Ferro R Fochesato Colombani S Dental caries in children with asthma undergoing treatment with short-acting beta2-agonists Eur J Paediatr Dent 2008 9 132 8 18844442
  14. [15]Mehta A Sequeira PS Sahoo RC Bronchial asthma and dental caries risk: Results from a case control study J Contemp Dent Pract 2009 10 59 66 19575055
  15. [16]Van Houte J Gibbons RJ Pulkkinen AJ Ecology of human oral lactobacilli Infect Immun 1972 6 723 9 4637297 PMC422600
  16. [17]Ikeda T Sandham HJ Bradley EL Jr Changes in Streptococcus mutans and lactobacilli in plaque in relation to the initiation of dental caries in Negro children Arch Oral Biol 1973 18 555 66 4516068
  17. [18]Brigic A Kobaslija S Zukanovic A Anti-asthmatic inhaled medications as favouring factors for increased concentration of Streptococcus mutans Mater Sociomed 2015 27 237 40 26543413 PMC4610621
  18. [20]Botelho MP Maciel SM Cerci Neto A Dezan CC Fernandes KB de Andrade FB Cariogenic microorganisms and oral conditions in asthmatic children Caries Res 2011 45 386 92 21822017
  19. [21]Alaki SM Ashiry EA Bakry NS Baghlaf KK Bagher SM The effects of asthma and asthma medication on dental caries and salivary characteristics in children Oral Health Prev Dent 2013 11 113 20 23534042
  20. [22]Ersin NK Gülen F Eronat N Cogulu D Demir E Tanaç R Oral and dental manifestations of young asthmatics related to medication, severity and duration of condition Pediatr Int 2006 48 549 54 17168972
  21. [24]Lenander-Lumikari M Laurikainen K Kuusisto P Vilja P Stimulated salivary flow rate and composition in asthmatic and non-asthmatic adults Arch Oral Biol 1998 43 151 6 9602294
  22. [25]Komiyama EY Ribeiro PM Junqueira JC Koga-Ito CY Jorge AO Prevalence of yeasts in the oral cavity of children treated with inhaled corticosteroids Braz Oral Res 2004 18 197 201 15619871
  23. [27]Shaw NJ Edmunds AT Inhaled beclomethasone and oral candidiasis Arch Dis Child 1986 61 788 90 3740927 PMC1777949
  24. [28]Kargul B Tanboga I Ergeneli S Karakoc F Dagli E Inhaler medicament effects on saliva and plaque pH in asthmatic children J Clin Pediatr Dent 1998 22 137 40 9643188

Cited by

Sorted by citations

Authors
Nandini, D., Ashuja, R., Vidyasagar, B., Ashwini, R., Donoghue, M., & Madhushankari, G.
Affiliations
Regional Institute of Medical Sciences (IN)
Corresponding author
Nandini, DB
Venue
Journal of Oral and Maxillofacial Pathology
Published
2018
Volume
22
Issue
1
Pages
144
ISSN
0973-029X (ISSN-L)
OpenAlex
W2807198543
Cited by
4
References
0
Citations by year
2024: 1 · 2023: 1 · 2020: 2
FWCI
0.57
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Journal of Oral and Maxillofacial Pathology (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Health Sciences › Dentistry › Periodontics › Dental Health and Care Utilization
  • Health Sciences › Dentistry › Periodontics › Oral Health Pathology and Treatment
Keywords
asthma, Streptococcus mutans, lactobacilli, Candida albicans, oral candidiasis, beta2-adrenergic agonists, corticosteroids, dental plaque, saliva, caries risk, adults

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review